Summary & Overview
HCPCS C8011: Hypoglossal Neurostimulator Implantation
HCPCS Level II code C8011 denotes open surgical implantation of a hypoglossal nerve neurostimulator system, encompassing electrode arrays, a receiver, external power source, and all system components. This code captures a specialized surgical procedure used to implant neurostimulation hardware intended to modulate hypoglossal nerve activity, typically to address upper airway dysfunction.
Nationally, such procedures are clinically significant due to their role in treating patients for whom conservative therapies are ineffective. Payors included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Information readers will find includes clinical context for the procedure, the expected service setting (operating room in inpatient or outpatient surgical facilities), and the scope of work represented by the billing code.
The publication summarizes benchmarks and policy considerations relevant to this device implantation code, highlights coverage and coding clarifications from major payors where available, and outlines areas where additional documentation is commonly required for claims processing. Data not available in the input is noted explicitly for elements such as specific modifiers, associated taxonomies, ICD-10 diagnosis pairings, related codes, and service line details.
Billing Code Overview
HCPCS Level II code C8011 describes the open implantation of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver, including an external power source and all system components. This procedure involves surgical placement of a neurostimulation system that targets the hypoglossal nerve to manage conditions related to upper airway patency.
Service type: Surgical implantation of neurostimulation device
Typical site of service: Inpatient or outpatient surgical setting, operating room
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with moderate to severe obstructive sleep apnea (OSA) who is intolerant of or nonadherent to positive airway pressure therapy and meets implant criteria for hypoglossal nerve stimulation. The patient undergoes preoperative evaluation including sleep medicine consultation, polysomnography to document OSA severity, upper airway evaluation, and imaging as indicated. Preoperative counseling explains device implantation risks, device components, and post‑implant titration. On the day of surgery the patient receives general anesthesia and is positioned for a transcervical approach to the hypoglossal nerve. The surgical team performs open implantation of the hypoglossal nerve neurostimulator electrode array(s) adjacent to the distal hypoglossal nerve branches and implants the subcutaneous receiver and external power components as described by C8011. Intraoperative neuromonitoring may be used to confirm lead placement. The device is tested intraoperatively for stimulation thresholds and tongue motion. The patient is observed overnight or discharged same day per institution protocol, with postoperative wound care instructions and scheduled device activation and titration by the sleep medicine or device clinic typically 4–6 weeks after implantation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the day of a procedure |